Navigation Links
Registration Open for WBBA's Life Science Innovation Northwest 2011 Event Webcast
Date:2/16/2011

Northwest: Creating the Future
  • Global solutions, Local benefit
  • Lessons Learned:  How to Position your Company for Success

  • These preeminent programs highlight the growth and innovation in the Pacific Northwest's life science sector and features medical technology, diagnostics, and therapeutic innovations, as well as cutting-edge scientific and educational developments in global health. Using OttW's polling feature and SuperChat™ viewers can live chat and provide on-the-spot feedback from seats in Seattle and Asia, India, Australia, Scandinavia, and Germany.

    Through sponsorship of the live webcast, Global Health Nexus (GHN) http://globalhealthnexus.org/ further cements their leading position of enhancing connection and collaboration between the business and research communities. GHN wealth of expertise and resources support life science innovations throughout the year both regionally and globally.

    "At Global Health Nexus we are proud to partner with OttW in delivering this premier broadcast. At OttW we are leading the curve of change in event, training and education communications. It's happening now in the Pacific Northwest - this hub of energy and progress being made in Life Sciences will affect lives throughout the world. This progress belongs to everyone."  ~ John Vadino Founder One to the World™

    About One to the World (formerly Dynamic Webcasting) - http://www.onetotheworld.com


    '/>"/>
    SOURCE One to the World
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related biology technology :

    1. Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
    2. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
    3. LS9's UltraClean Diesel™ Receives EPA Registration
    4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
    5. Dempsey Challenge Participant Registration Officially Open
    6. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
    7. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
    8. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
    9. Cellu Tissue Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock
    10. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
    11. PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/30/2015)... , April 30, 2015 Oxford Finance LLC ... to life sciences and healthcare services companies, today announced ... loan agreement with Celula, Inc., a diagnostic testing company ... enabling better patient care and improved outcomes.  Proceeds of ... and expand the commercialization of its products in the ...
    (Date:4/30/2015)... 30, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... of biosimilar therapeutics including high value and difficult ... its previously announced underwritten public offering of 6,750,000 ... offering price of $15.50 per share. This includes ... their option to purchase up to 750,000 additional ...
    (Date:4/30/2015)... April 30, 2015 Available in ... http://www.lespausa.com , Fleur’s introduces ... combining the benefits of makeup, skin care and ... tinted cream is designed with specific complexion-correcting pigments ... even complexion and a healthy glow. Far more ...
    (Date:4/30/2015)... (PRWEB) April 30, 2015 Sterlitech ... ultrafiltration membranes, the PX, PY, and PZ ... sheets, and disks. Designed to be ideal ... new membranes can fill critical process requirements where ... downstream processes. , “New regulations on industrial wastewater ...
    Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 3Sterlitech Offers New Ultrafiltration Membranes 2
    ... Lixte,Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) today ... Bulletin Board under,the Symbol LIXT. Commenting on this ... "We believe that being a publicly traded company will,enable ... to us as,a private company. Having access to the ...
    ... of Cervical ... Cancer Risk, ... it has entered into an agreement to exclusively,license the Human Papillomavirus ... measurement of high-risk HPV types using,DNA-based detection. Quantovir is believed to ...
    ... MGCD0103,s Orphan Drug, Designation for the Treatment of ... BOULDER, Colo. and MONTREAL, Sept. 24 ,Pharmion Corporation ... MYG) today,announced that the European Medicines Agency (EMEA) ... deacetylase (HDAC),inhibitor, as an Orphan Medicinal Product for ...
    Cached Biology Technology:Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT 2Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT 3Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT 4Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 2Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 3Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 4Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma 4
    (Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
    (Date:4/1/2015)... Medisafe ™, the leading global medication management platform with ... Android smartphones and tablets, announces today that ... allow patients to track and correlate their adherence directly ... be able to visualize in real-time how taking medication ... glucose levels and blood pressure. "Patients need ...
    (Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
    Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
    ... a mashup of monster movies, but palaeontologists have discovered evidence ... killing that took place 4 million years ago. ... careful, forensic-style analysis of bite marks on an otherwise well-preserved ... reconstructed the events that led to the death of the ...
    ... years of satellite data have found that the amount of ... the last three decades. Most of the increase has occurred ... increase in tropical regions. The new analysis shows, ... degrees a line that runs through central Texas in ...
    ... heart-healthy, essential omega-3 fatty acid is about to improve ... advance will move biotechnology onto the average consumer,s daily ... deliver positive environmental impacts and increase production to feed ... on Horizon , Recently, the U.S. Food and Drug ...
    Cached Biology News:Jaws -- 4 million BC 2UV exposure has increased over the last 30 years, but stabilized since the mid-1990s 2UV exposure has increased over the last 30 years, but stabilized since the mid-1990s 3UV exposure has increased over the last 30 years, but stabilized since the mid-1990s 4New biotech advance to add heart healthy omega-3s to US diet 2
    Ps-Aeruginosa (IgA) -Ab EIA Sample Size: 100 l...
    Request Info...
    Candida (IgG) -Ab EIA Sample Size: 5 l...
    ... The Oxidized LDL Competitive ELISA is ... in the sample competes with a fixed amount ... for the binding of the biotin- labeled specific ... 25 l The Oxidized LDL Competitive Enzyme-Linked ...
    Biology Products: